Randomized clinical trial of surgical vs. percutaneous vs. hybrid revasculatization in multivessel coronary artery disease: 3 years follow-up (the HREVS Trial)
29 August 2020 (00:00 - 00:00)
Organised by:
About the speaker

Research Institute for Complex Issues of Cardiovascular Diseases, Kemerovo (Russian Federation)
5 More presentations in this session
Professor M. Pontes (Porto Alegre, BR)
Assistant Professor F. Pollari (Nuremberg, DE)
Access the full session
The Event
ESC Congress 2020
29 August - 1 September 2020

